NKTR

Q: What is the price of Nektar Therapeutics (NKTR) today?

The price of Nektar Therapeutics (NKTR) today is $ 76.99, with return of 830% compared to the last year. The price of Nektar Therapeutics (NKTR) started the year trading around $ 42.28 and today it is at $ 76.99. Follow the real-time price chart, the historical price of Nektar Therapeutics (NKTR) and international markets.

Q: When does Nektar Therapeutics (NKTR) pay dividends?

Nektar Therapeutics (NKTR) did not distribute dividends in the last year.

Q: Is Nektar Therapeutics (NKTR) worth it?

Currently, Nektar Therapeutics (NKTR) is priced at $ 76.99, with a P/E of -9.39%, representing a deviation of -1,440% from its historical average P/E. In the last year, the stock showed a variation of 830 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 830.00%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy Nektar Therapeutics (NKTR) stock?

Investing in stocks of Nektar Therapeutics (NKTR) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of Nektar Therapeutics (NKTR) yield today?

The yield of Nektar Therapeutics (NKTR) was 6.27% in the last month, 830.00% in the last year and -74.65% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.If you wanted to buy 100 stocks of Nektar Therapeutics (NKTR) today, the total investment would be $ 7,699.00, based on the current price of $ 76.99.If past performance were to repeat, the return on your investment would be:In 1 year: $ 71,600.70In 5 years: $ 1,951.70In 10 years: $ 2,608.42It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Nektar Therapeutics

Price

$ 76.99

return (12m)

830.00%

p/e

-9.39

p/bv

17.14

DIVIDEND YIELD

0.00%

NKTR price

NKTR

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment NKTR

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

6.27%

3 months

77.31%

1 year

830.00%

2 years

288.84%

5 years

-74.65%

10 years

-66.12%

Fundamentals NKTR

review the fundamentals of Nektar Therapeutics shares

P/E

-9.39

Sector: -5.82 Industry: -5.82

P/S (PSR)

27.87

Sector: -4.74 Industry: -4.74

P/BV

17.14

Sector: 1.40 Industry: 1.40

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

-58.51%

Sector: -72.38% Industry: -72.38%

ROE

-182.64%

Sector: -84.15% Industry: -84.15%

ROIC

-172.85%

Sector: -1,194.38% Industry: -1,194.38%

NET MARGIN

-100.00%

Sector: -46.16% Industry: -46.16%

GROSS MARGIN

100.00%

Sector: 35.92% Industry: 35.92%

OPERATING MARGIN

-100.00%

Sector: -46.05% Industry: -46.05%

EV/EBITDA

-11.96

Sector: -5.52 Industry: -5.52

EV/EBIT

-11.91

Sector: -5.77 Industry: -5.77

PRICE-TO-ASSETS

5.49

Sector: 1.13 Industry: 1.13

BVPS

4.49

Sector: 1.63 Industry: 1.63

EPS

-8.20

Sector: -2.73 Industry: -2.73

EQUITY-TO-ASSETS RATIO

0.32

Sector: 0.32 Industry: 0.32

LIABILITIES / ASSETS

0.68

Sector: 0.33 Industry: 0.33

CAGR REVENUE 5 YEARS

-11.53%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

-20.72%

Sector: - Industry: -

Fundamentals NKTR

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	21.84	7.39	33.81%	2.14%	$ 585.48 B	28.46%
PFE	20.72	1.73	8.35%	6.07%	$ 161.03 B	12.42%
ABBV	87.32	0.00	0.00%	3.18%	$ 369.02 B	6.91%
NVO	10.48	5.40	51.50%	4.56%	$ 164.23 B	33.05%
MRK	16.43	0.00	0.00%	2.71%	$ 300.00 B	28.08%
AZN	30.87	6.48	20.99%	1.57%	$ 315.61 B	17.41%
GILD	20.39	7.67	37.62%	2.28%	$ 173.52 B	28.90%
BMY	17.20	-3.56	-20.72%	4.18%	$ 121.35 B	14.64%
ZTS	19.33	15.51	80.25%	1.72%	$ 51.66 B	28.23%
REGN	17.42	2.51	14.41%	0.47%	$ 78.47 B	31.41%
HALO	24.01	155.91	649.21%	0.00%	$ 7.61 B	22.69%
AMGN	24.32	21.66	89.06%	2.78%	$ 187.54 B	20.98%
MCK	25.06	-1,098.65	-4,383.84%	0.36%	$ 108.77 B	1.09%
VRTX	28.19	5.97	21.18%	0.00%	$ 111.43 B	32.94%
CAH	30.39	-18.71	-61.56%	0.95%	$ 50.52 B	0.68%
ADMA	14.89	4.58	30.78%	0.00%	$ 2.19 B	28.80%
BIIB	20.16	1.43	7.08%	0.00%	$ 26.07 B	13.07%
HRMY	9.96	1.82	18.24%	0.00%	$ 1.58 B	18.27%

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

NKTR Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Nektar Therapeutics

Nektar Therapeutics

Average Investor10 user rating

4.0 (0 people)

United States

36 years

Founded: 1990

1994

Time since IPO - 32 years

718

Employees

The Company Nektar Therapeutics (United States), is listed on Nasdaq with a market value of $ 1.54 Billion, having an equity of $ 89.83 Millions.

With a total of 718 employees, the company is listed in the sector of Health Care and categorized in industry of Biotechnology.

In the last 12 months the Company had a revenue of $ 55.24 Millions, which generated a loss in the amount of $ -164.07 Millions.

As for its main indicators, the Company has a P/E ratio of -9.39, a P/BV ratio of 17.14 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker NKTR.

Market cap

$ 1.54 Billion

Net worth

$ 89.83 Millions

US$ 89,830,000.00

Assets

$ 280.41 Millions

US$ 280,410,000.00

Total Shares Outstanding

20.00 Millions

20,000,000

Average Daily Trading Volume

$ 1.21 Million

US$ 1,210,509.52

Sector

Health Care

Industry

Biotechnology

NKTR

NKTR revenue and profits

Financial Results NKTR

DRAG THE FRAME TO SEE MORE DATA

NKTR cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 884.28 29,96% (12M)

P/E

25.06

0.36%

ROE

-4,383.84%

P/BV

-1,098.65

CAH - Cardinal Health

$ 214.05 67,60% (12M)

P/E

30.39

0.95%

ROE

-61.56%

P/BV

-18.71

JNJ - Johnson & Johnson

$ 243.04 63,02% (12M)

P/E

21.84

2.14%

ROE

33.81%

P/BV

7.39

PFE - Pfizer

$ 28.32 32,24% (12M)

P/E

20.72

6.07%

ROE

8.35%

P/BV

1.73

ABBV - AbbVie

$ 208.84 16,32% (12M)

P/E

87.32

3.18%

ROE

0.00%

P/BV

0.00

MRK - Merck & Co.

$ 120.87 55,08% (12M)

P/E

16.43

2.71%

ROE

0.00%

P/BV

0.00

AZN - AstraZeneca

$ 203.49 57,42% (12M)

P/E

30.87

1.57%

ROE

20.99%

P/BV

6.48

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 884.28 29,96% (12 M)

P/L

25.06

0.36%

ROE

-4,383.84%

P/VP

-1,098.65

CAH - Cardinal Health

$ 214.05 67,60% (12 M)

P/L

30.39

0.95%

ROE

-61.56%

P/VP

-18.71

JNJ - Johnson & Johnson

$ 243.04 63,02% (12 M)

P/L

21.84

2.14%

ROE

33.81%

P/VP

7.39

PFE - Pfizer

$ 28.32 32,24% (12 M)

P/L

20.72

6.07%

ROE

8.35%

P/VP

1.73

ABBV - AbbVie

$ 208.84 16,32% (12 M)

P/L

87.32

3.18%

ROE

0.00%

P/VP

0.00

MRK - Merck & Co.

$ 120.87 55,08% (12 M)

P/L

16.43

2.71%

ROE

0.00%

P/VP

0.00

AZN - AstraZeneca

$ 203.49 57,42% (12 M)

P/L

30.87

1.57%

ROE

20.99%

P/VP

6.48

Frequently Asked Questions

What is the price of Nektar Therapeutics (NKTR) today?

The price of Nektar Therapeutics (NKTR) today is $ 76.99, with return of 830% compared to the last year. The price of Nektar Therapeutics (NKTR) started the year trading around $ 42.28 and today it is at $ 76.99. Follow the real-time price chart, the historical price of Nektar Therapeutics (NKTR) and international markets.

When does Nektar Therapeutics (NKTR) pay dividends?

Nektar Therapeutics (NKTR) did not distribute dividends in the last year.

Is Nektar Therapeutics (NKTR) worth it?

Currently, Nektar Therapeutics (NKTR) is priced at $ 76.99, with a P/E of -9.39%, representing a deviation of -1,440% from its historical average P/E. In the last year, the stock showed a variation of 830 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 830.00%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How can I buy Nektar Therapeutics (NKTR) stock?

Investing in stocks of Nektar Therapeutics (NKTR) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much would 100 shares of Nektar Therapeutics (NKTR) yield today?

The yield of Nektar Therapeutics (NKTR) was 6.27% in the last month, 830.00% in the last year and -74.65% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.

If you wanted to buy 100 stocks of Nektar Therapeutics (NKTR) today, the total investment would be $ 7,699.00, based on the current price of $ 76.99.

If past performance were to repeat, the return on your investment would be:

In 1 year: $ 71,600.70
In 5 years: $ 1,951.70
In 10 years: $ 2,608.42

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

NKTR

Nektar Therapeutics

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment NKTR

review the fundamentals of Nektar Therapeutics shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

If you had invested (change) 2 years years ago, ago, you would now have

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Nektar Therapeutics

Nektar Therapeutics

United States

36 years

1994

718

PROFIT X PRICE NKTR

Financial Results NKTR

NKTR cash flow

Asset, Revenue and Profit Growth - NKTR

NKTR balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

PFE - Pfizer

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

Frequently Asked Questions